Provided by Tiger Trade Technology Pte. Ltd.

Shattuck Labs, Inc.

4.85
+0.12002.54%
Volume:77.44K
Turnover:369.07K
Market Cap:306.91M
PE:-4.97
High:4.88
Open:4.56
Low:4.56
Close:4.73
52wk High:4.89
52wk Low:0.6922
Shares:63.28M
Float Shares:24.15M
Volume Ratio:3.41
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9753
EPS(LYR):-1.4857
ROE:-57.84%
ROA:-33.93%
PB:3.29
PE(LYR):-3.26

Loading ...

Shattuck Labs Shares Rise After HC Wainwright Upgrade

MT Newswires Live
·
Dec 02, 2025

Shattuck Labs Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
Dec 01, 2025

HC Wainwright Upgrades Shattuck Labs to Buy From Neutral, Price Target is $6

MT Newswires Live
·
Dec 01, 2025

Shattuck Labs Inc : H.c. Wainwright Raises to Buy From Neutral

THOMSON REUTERS
·
Dec 01, 2025

Shattuck Labs to Participate in Upcoming December Investor Conferences

GlobeNewswire
·
Nov 20, 2025

Shattuck Labs Q3 Net Income USD -10.056 Million

Reuters
·
Nov 20, 2025

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK)

TIPRANKS
·
Nov 08, 2025

Shattuck Labs: Hold Rating Amidst Key Milestones and Strong Financial Position

TIPRANKS
·
Nov 08, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Shattuck Labs (STTK) and ICU Medical (ICUI)

TIPRANKS
·
Nov 07, 2025

Shattuck Labs Reports Improved Financial Performance

TIPRANKS
·
Nov 07, 2025

Shattuck Labs Unveils Pipeline Advancements Targeting Inflammatory and Immune-Mediated Diseases

Reuters
·
Nov 07, 2025

Shattuck Labs reports Q3 EPS (14c), consensus (15c)

TIPRANKS
·
Nov 07, 2025

Shattuck Labs Q3 EPS $(0.14), Inline, Sales $1.000M Down From $2.997M YoY, Cash Balance Of $86.1M Expected To Provide Cash Runway Into 2029

Benzinga
·
Nov 07, 2025

Shattuck Labs reports third quarter 2025 financial results

Reuters
·
Nov 07, 2025

BRIEF-Shattuck Labs Q3 Net Income USD -10.056 Million

Reuters
·
Nov 07, 2025

Shattuck Labs Q3 Collaboration Revenue USD 1 Million

THOMSON REUTERS
·
Nov 07, 2025

Shattuck Labs’ SL-325 Phase 1 Trial: A Key Development in Biopharmaceuticals

TIPRANKS
·
Oct 28, 2025

Shattuck Labs (STTK) Gets a Hold from Citi

TIPRANKS
·
Oct 14, 2025

Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel

GlobeNewswire
·
Oct 02, 2025

Shattuck Labs files to sell 105.27M shares of common stock for holders

TIPRANKS
·
Sep 19, 2025